AviSia Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$408K
- Investors
-
2
AviSia Therapeutics General Information
Description
Developer of antigen-specific immunotherapies intended to treat autoimmune diseases. The company provides immune-modulating therapeutics, primarily focused on type 1 diabetes, enabling patients to have immune tolerance and reduced autoimmune activity while creating lifelong protection against such diseases.
Contact Information
Website
www.avisiatherapeutics.comCorporate Office
- Roetersstraat 35
- 1018 WB Amsterdam
- Netherlands
Corporate Office
- Roetersstraat 35
- 1018 WB Amsterdam
- Netherlands
AviSia Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Sep-2025 | $408K | Completed | Generating Revenue | ||
| 1. University Spin-Out | 01-Jan-2024 | Completed | Generating Revenue |
AviSia Therapeutics Signals
AviSia Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovatiefonds Noord-Holland | Venture Capital | Minority | ||
| Amsterdam University Medical Center | Corporation |
AviSia Therapeutics FAQs
-
When was AviSia Therapeutics founded?
AviSia Therapeutics was founded in 2024.
-
Where is AviSia Therapeutics headquartered?
AviSia Therapeutics is headquartered in Amsterdam, Netherlands.
-
What is the size of AviSia Therapeutics?
AviSia Therapeutics has 4 total employees.
-
What industry is AviSia Therapeutics in?
AviSia Therapeutics’s primary industry is Drug Discovery.
-
Is AviSia Therapeutics a private or public company?
AviSia Therapeutics is a Private company.
-
What is AviSia Therapeutics’s current revenue?
The current revenue for AviSia Therapeutics is .
-
How much funding has AviSia Therapeutics raised over time?
AviSia Therapeutics has raised $408K.
-
Who are AviSia Therapeutics’s investors?
Innovatiefonds Noord-Holland and Amsterdam University Medical Center have invested in AviSia Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process